Hypertension and Health-Related Quality of Life Adherence: Cross- sectional Observational Study in Ambulatory Patients
21 Years +
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
No locations available
Patients with diagnosis of essential hypertension under the criteria established by the Joint National Committee VII (9) and those patients under pharmacological treatment with the same therapeutic regime during at least the last 6 months.